Unlocking Precision Medicine in Psychiatry: Targeting KAT III as a unique Concept for the Treatment of Immune-induced Cognitive Impairment and Psychosis.
We use cookies to keep your session secure, remember your preferences, and analyse site traffic with Google Analytics.
By continuing to use GrantFunds you agree to our
Privacy Policy
and
Terms of Use.